Replies to post #75588 on Anavex Life Sciences Corp (AVXL)

[nobrainerstocks]

My point was to show that apparantly Tobira was hyped just as Anavex was (and also sued), but that nothing is impossible for a clinical stage bio company with no drugs approved. What is unusual about the Tobira deal is that Allergan pays a huge premium.

Let's hope that Anavex will deliver.